OTCMKTS:FTCY

Global Future City Competitors

$0.0000

0.00 (0.00 %)

(As of 01/24/2020)

Add

Compare

Today's Range

$0.00

▼

$0.00

50-Day Range

$0.00

▼

$0.05

52-Week Range

$0.05

▼

$1.00

Volume16 shs

Average Volume4,221 shs

Market Capitalization$40.66

P/E RatioN/A

Dividend YieldN/A

Beta-0.61

Global Future City (OTCMKTS:FTCY) Vs. ACUS, AFFY, ARYX, AHROQ, CBPI, and CDSG

Should you be buying FTCY stock or one of its competitors? Companies in the industry of "pharmaceutical preparations" are considered alternatives and competitors to Global Future City, including Acusphere (ACUS), Affymax (AFFY), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), China Botanic Pharmaceutical (CBPI), and China Dongsheng International (CDSG).

Global Future City vs. Acusphere Stock

Acusphere (OTCMKTS:ACUS) and Global Future City (OTCMKTS:FTCY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability and analyst recommendations.

Volatility and Risk

Acusphere has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500. Comparatively, Global Future City has a beta of -0.61, meaning that its share price is 161% less volatile than the S&P 500.

Profitability

This table compares Acusphere and Global Future City's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acusphere	N/A	N/A	N/A
Global Future City	N/A	N/A	N/A

Earnings and Valuation

This table compares Acusphere and Global Future City's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acusphere	N/A	N/A	N/A	N/A	N/A
Global Future City	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent recommendations for Acusphere and Global Future City, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acusphere	0	0	0	0	N/A
Global Future City	0	0	0	0	N/A

Summary

Acusphere beats Global Future City on 1 of the 1 factors compared between the two stocks.

Global Future City vs. Affymax Stock

Global Future City (OTCMKTS:FTCY) and Affymax (OTCMKTS:AFFY) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

Valuation and Earnings

This table compares Global Future City and Affymax's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Future City	N/A	N/A	N/A	N/A	N/A
Affymax	N/A	N/A	N/A	N/A	N/A

Volatility & Risk

Global Future City has a beta of -0.61, meaning that its share price is 161% less volatile than the S&P 500. Comparatively, Affymax has a beta of 2.77, meaning that its share price is 177% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for Global Future City and Affymax, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Future City	0	0	0	0	N/A
Affymax	0	0	0	0	N/A

Profitability

This table compares Global Future City and Affymax's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Future City	N/A	N/A	N/A
Affymax	N/A	N/A	N/A

Summary

Affymax beats Global Future City on 1 of the 1 factors compared between the two stocks.

Global Future City vs. ARYx Therapeutics Stock

ARYx Therapeutics (OTCMKTS:ARYX) and Global Future City (OTCMKTS:FTCY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation.

Profitability

This table compares ARYx Therapeutics and Global Future City's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ARYx Therapeutics	N/A	N/A	N/A
Global Future City	N/A	N/A	N/A

Volatility and Risk

ARYx Therapeutics has a beta of -0.53, meaning that its share price is 153% less volatile than the S&P 500. Comparatively, Global Future City has a beta of -0.61, meaning that its share price is 161% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and price targets for ARYx Therapeutics and Global Future City, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ARYx Therapeutics	0	0	0	0	N/A
Global Future City	0	0	0	0	N/A

Earnings & Valuation

This table compares ARYx Therapeutics and Global Future City's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ARYx Therapeutics	N/A	N/A	N/A	N/A	N/A
Global Future City	N/A	N/A	N/A	N/A	N/A

Summary

ARYx Therapeutics beats Global Future City on 1 of the 1 factors compared between the two stocks.

Global Future City vs. AtheroNova Stock

Global Future City (OTCMKTS:FTCY) and AtheroNova (OTCMKTS:AHROQ) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Profitability

This table compares Global Future City and AtheroNova's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Future City	N/A	N/A	N/A
AtheroNova	N/A	N/A	N/A

Valuation and Earnings

This table compares Global Future City and AtheroNova's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Future City	N/A	N/A	N/A	N/A	N/A
AtheroNova	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Global Future City and AtheroNova, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Future City	0	0	0	0	N/A
AtheroNova	0	0	0	0	N/A

Risk & Volatility

Global Future City has a beta of -0.61, suggesting that its share price is 161% less volatile than the S&P 500. Comparatively, AtheroNova has a beta of -8.71, suggesting that its share price is 971% less volatile than the S&P 500.

Summary

Global Future City beats AtheroNova on 1 of the 1 factors compared between the two stocks.

Global Future City vs. China Botanic Pharmaceutical Stock

China Botanic Pharmaceutical (OTCMKTS:CBPI) and Global Future City (OTCMKTS:FTCY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

Valuation & Earnings

This table compares China Botanic Pharmaceutical and Global Future City's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
China Botanic Pharmaceutical	N/A	N/A	N/A	N/A	N/A
Global Future City	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares China Botanic Pharmaceutical and Global Future City's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
China Botanic Pharmaceutical	N/A	N/A	N/A
Global Future City	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current recommendations for China Botanic Pharmaceutical and Global Future City, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
China Botanic Pharmaceutical	0	0	0	0	N/A
Global Future City	0	0	0	0	N/A

Risk and Volatility

China Botanic Pharmaceutical has a beta of 17.09, suggesting that its stock price is 1,609% more volatile than the S&P 500. Comparatively, Global Future City has a beta of -0.61, suggesting that its stock price is 161% less volatile than the S&P 500.

Summary

China Botanic Pharmaceutical beats Global Future City on 1 of the 1 factors compared between the two stocks.

Global Future City vs. China Dongsheng International Stock

Global Future City (OTCMKTS:FTCY) and China Dongsheng International (OTCMKTS:CDSG) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Global Future City and China Dongsheng International, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Future City	0	0	0	0	N/A
China Dongsheng International	0	0	0	0	N/A

Profitability

This table compares Global Future City and China Dongsheng International's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Future City	N/A	N/A	N/A
China Dongsheng International	N/A	N/A	N/A

Earnings & Valuation

This table compares Global Future City and China Dongsheng International's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Future City	N/A	N/A	N/A	N/A	N/A
China Dongsheng International	N/A	N/A	N/A	N/A	N/A

Volatility & Risk

Global Future City has a beta of -0.61, indicating that its share price is 161% less volatile than the S&P 500. Comparatively, China Dongsheng International has a beta of 13.38, indicating that its share price is 1,238% more volatile than the S&P 500.

Summary

China Dongsheng International beats Global Future City on 1 of the 1 factors compared between the two stocks.